Wall Street Zen raised Fonar to a "hold" rating in a research report on Friday...
MarketBeat·12d ago
More News
LSV Asset Management Reduces Stake in Fonar Corporation $FONR
LSV Asset Management lowered its position in shares of Fonar Corporation (NASDAQ:FONR - Free Report) by 40.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·18d ago
FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit
FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.
Zacks·27d ago
Fonar (NASDAQ:FONR) Issues Earnings Results
Fonar (NASDAQ:FONR - Get Free Report) issued its earnings results on Monday. The medical equipment provider reported $0.34 earnings per share (EPS) for the quarter. Fonar had a return on equity of...
MarketBeat·30d ago
FONAR Stock Dips Post FY25 Earnings on Lower Profit and Higher Costs
FONR reports higher costs and lower profits in fiscal 2025, despite increases in scan volumes and imaging service revenues.
Zacks·3mo ago
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
FONR leverages hybrid MRI tech and a strong balance sheet to navigate industry headwinds, though rising costs and regulatory risks tied to claim collections remain key challenges.
Zacks·3mo ago
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONAR
SAP, NVO, TMO and FONR navigate growth and headwinds as analysts spotlight cloud momentum, obesity drugs, and innovation plays.
Zacks·5mo ago
Top Research Reports for SAP, Novo Nordisk & Thermo Fisher
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
Zacks·5mo ago
FONR Stock Rises Following Q3 Earnings on Higher Net Income